Viking Global Investors’ $200 Million PIPE Investment in Inhibrx

Cleary Gottlieb represented Viking Global Investors in the transaction.Viking Global Investors announced a PIPE investment in Inhibrx, Inc., a clinical-stage biopharmaceutical company dedicated to the development…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now